Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Can Guven

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Scottish Medical Journal|May 10, 2018
A rare cause of proximal muscle weakness: immune necrotising myopathyDeniz Can Guven, Abdulsamet Erden, Levent Kilic, et al.
Clinical Nutrition ESPEN|March 29, 2025
Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysisOnur Bas, Taha Koray Sahin, Latif Karahan, et al.
Current Medical Research and Opinion|December 24, 2024
The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional studyTaha Koray Sahin, Yunus Kaygusuz, Mehmet Cihan İcli, et al.
Future Oncology (London, England)|August 19, 2021
The association of BMI and sarcopenia with survival in patients with glioblastoma multiformeDeniz Can Guven, Melek Seren Aksun, Ibrahim Yahya Cakir, et al.
The Laryngoscope|May 25, 2023
Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-AnalysisDeniz Can Guven, Bettzy Stephen, Taha Koray Sahin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 19, 2020
Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case reportDeniz Can Guven, Saadettin Kilickap, Hasan Cagri Yildirim, et al.
Expert Review of Anticancer Therapy|December 14, 2024
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancerGozde Kavgaci, Taha Koray Sahin, Tugcenur Muderrisoglu, et al.
Cancers|June 10, 2022
The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-AnalysisDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Future Oncology (London, England)|December 19, 2022
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisDeniz Can Guven, Enes Erul, Taha Koray Sahin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic InflammationEnes Ucgul, Deniz Can Guven, Aybala Nur Ucgul, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Scottish Medical Journal|May 10, 2018
A rare cause of proximal muscle weakness: immune necrotising myopathyDeniz Can Guven, Abdulsamet Erden, Levent Kilic, et al.
Clinical Nutrition ESPEN|March 29, 2025
Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysisOnur Bas, Taha Koray Sahin, Latif Karahan, et al.
Current Medical Research and Opinion|December 24, 2024
The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional studyTaha Koray Sahin, Yunus Kaygusuz, Mehmet Cihan İcli, et al.
Future Oncology (London, England)|August 19, 2021
The association of BMI and sarcopenia with survival in patients with glioblastoma multiformeDeniz Can Guven, Melek Seren Aksun, Ibrahim Yahya Cakir, et al.
The Laryngoscope|May 25, 2023
Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-AnalysisDeniz Can Guven, Bettzy Stephen, Taha Koray Sahin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 19, 2020
Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case reportDeniz Can Guven, Saadettin Kilickap, Hasan Cagri Yildirim, et al.
Expert Review of Anticancer Therapy|December 14, 2024
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancerGozde Kavgaci, Taha Koray Sahin, Tugcenur Muderrisoglu, et al.
Cancers|June 10, 2022
The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-AnalysisDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Future Oncology (London, England)|December 19, 2022
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisDeniz Can Guven, Enes Erul, Taha Koray Sahin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic InflammationEnes Ucgul, Deniz Can Guven, Aybala Nur Ucgul, et al.
Pageof 14